Massachusetts General Hospital (MGH) announced that it will serve as a key testing site for a clinical analytical study involving Philips’ digital pathology whole slide imaging (WSI) IntelliSite Solution. The study is designed to show the reproducibility of the IntelliSite pathology solution in disease detection as part of the industry’s efforts to obtain regulatory clearance of WSI for primary diagnostic use. If approved for diagnosis, in contrast to the industry’s current analog process, soon
Read More
Digital Pathology
Philips, Genomic Health Partner to Utilize Innovative Digital Pathology
Royal Philips has announced a collaboration with Genomic Health, Inc., a provider of genomic-based diagnostic tests, to leverage Philips digital pathology tools in Genomic Health’s continuing scale up of its molecular diagnostic testing processes. Pathology involves the examination of patient tissue samples and plays a crucial role in the diagnosis and treatment of a wide variety of diseases, including cancer. Pathologic evaluation of tumor tissue specimens is a critical step in the genomic
Read More
